cell based model Flashcards
cascade model
contact activation sequence:
intrinsic (within blood vessel)
XII - XI - IX - (VIII) - X
extrinsic - outside of blood vessel:
VII, tf Ca++ - X
common:
X - V - II (prothrombin) - I (fibrinogen)
XIII
Tenase complex
prothrombinase complex:
VIIIa-IXa
Xa-Va
vit K dépendant
Ca++ cofactor
II, VII, IX, X
II, VII, IX, X XI
limitations of cascade model:
- assume redundant and indep. -not the case
- yet Hagmeman def >PTT but no clinical bleeding - in vitro not in vivo
2 fundamental paradigm shifts w cell based model:
- TF primary initiator of coagulation (not contact activation/intrinsic path)
- coagulation is localized and controlled on cellular surfaces
G1a glutamic acid residues allow for what?:
must be carboxylated by:
vit K antagonists prevent G1a
binding of Ca++
vit K dependent epoxside reductase
G1a glutamic acid residue binding (II,VII,IX,X)
- role of cell membrane surface:
external leaf is neutral - composed of:
- sphingomyelin
- sphingolipids
- PC phosphatidyl-choline
cell membrane surface:
internal leaf - composed of:
- PS - phospatidyl-serine
2. PE - phosphatidyl-ethanolamine
resting state: Flippase:
Floppase:
injury: scramblase:
PS returned to internal
PC returned to external
PS & PE to external
(phospatidyl-serine/ethanolamine)
- role of microparticles:
what is MP:
derived from:
activated by:
intact vesicles derived from cells
size 2–20% of the size of a RBC
arise when activated or apopototic cells shed bits of membrane
derived from plt, endothelial cells, and monocyte - in inflam also RBC and granulocytes
Cytokines (TNFa, IL-6), thrombin, shear stress, and hypoxia can stimulate MP formation
MP contain:
cell surface proteins similar to those found on their parent cell (eg, ultra large vWF monomers on endothelial cell-derived MPs, P-selectin on platelet-derived MPs, TF on monocyte-derived MPs)
can participate in coagulation reactions, especially when the MP expresses a procoagulant membrane
Hypercoagulability, or thrombophilia, describes:
Causes may include:
a propensity for inappropriate thrombus formation
- increases in procoagulant elements
- altered blood flow
- endothelial barrier disruption
- decreases in endogenous anticoagulants
- decrease in fibrinolysis
endothelial barrier disruption
inflammation thins:
4. decreases in endogenous anticoagulants
5. decrease in fibrinolysis
EGC
- = < heparan sulfate (most abundant anticoagulant)
- TFPI TF pathway inhib also found in EGC